Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Yogic Eye Exercises for Computer Vision Syndrome in Female Design Students

13 september 2026 uppdaterad av: Nada Aldahlawi, King Saud University

Effect of a Four-Week Yogic Eye Exercise Program on Computer Vision Syndrome Symptoms in Female University Students: A Single-Arm Pre-Post Study

Computer vision syndrome (CVS) is a cluster of eye and musculoskeletal complaints - dryness, redness, blurred vision, foreign body sensation, excessive tearing, and neck, shoulder or back pain - that arises from prolonged work at a digital display. It is common among university students, and optical, pharmacological and nutritional treatments have given inconsistent results. Yoga-based eye exercises have been proposed as a brief, inexpensive alternative that requires no equipment.

This study tested whether a short, structured programme of yogic eye exercises reduces self-reported CVS symptoms in female undergraduates in a graphic design and digital media programme, a group whose coursework demands sustained, colour-critical near work at a screen.

All 36 female students enrolled in the programme took part. Each attended one supervised training session and then performed a 13-minute sequence of relaxation exercises (slow blinking, gazing at a distant target, acupressure around the eyes) and strengthening exercises (eye rolling, nose-tip gazing) three days a week for four weeks, a total of 12 sessions, reporting completion of each session on the same day.

Nine symptoms - five ocular and four musculoskeletal - were rated on a four-point scale (never, rarely, sometimes, always) at the start and again at the end of week 4. The main question was whether the average of all nine ratings fell over the four weeks. Every participant served as her own comparison; there was no control group and no masking.

Studieöversikt

Detaljerad beskrivning

Design. Single-arm, pre-post interventional study in which each participant served as her own control, conducted in the Graphic Design and Digital Media programme of Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. No control group was recruited and no masking was applied.

Participants. All 36 female students enrolled in the programme were invited and all agreed, so the convenience sample was a complete enumeration of the eligible cohort. The programme admits female students only. All participants were in the 18-22 year age band.

Intervention. Participants were trained in a single supervised group session before baseline and given written and illustrated instructions. Each session comprised relaxation exercises (slow blinking; gazing at a fine detail of a distant target; acupressure massage of periocular points) followed by strengthening exercises (eye-rolling movements; nose-tip gazing, in which the participant focuses on the extended thumb, moves it slowly toward the nose tip, holds for five seconds and moves it away). The combined sequence took approximately 13 minutes and was performed three days per week for four consecutive weeks, giving 12 sessions in total. After the training session participants practised independently and reported completion of each session the same day in a monitored group thread, so adherence was verified session by session rather than recalled at the end.

Assessment. Symptoms were assessed with an adapted electronic questionnaire administered at baseline and at the end of week 4. The instrument was developed by reviewing validated instruments in the literature, refining items with subject-matter experts and pilot testing in six female students. It recorded demographic details, medical history relevant to ocular surface dryness, habitual computer use, and nine symptom items each rated on a 4-point Likert scale (1 = never, 2 = rarely, 3 = sometimes, 4 = always). The identical instrument and platform were used at both time points.

Analysis. The primary outcome, the total symptom score, and the two domain scores were compared with the paired-samples t-test, with the Wilcoxon signed-rank test reported alongside where normality was not supported; item-level differences were tested with the Wilcoxon signed-rank test. Because nine item-level comparisons were made, p-values were adjusted by the Holm-Bonferroni procedure. No data were imputed and no subgroup or interaction analyses were performed. No formal a priori sample size calculation was performed; the study enrolled the entire eligible cohort.

Registration. This record was created retrospectively. The study was investigator-initiated and approved by the Princess Nourah bint Abdulrahman University Institutional Review Board on 20 December 2020, before the first participant was enrolled on 15 March 2021. The design, intervention and outcome measures recorded here are those specified in the approved protocol and are unchanged.

Studietyp

Interventionell

Inskrivning (Faktisk)

36

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Riyadh, Saudiarabien, 11671
        • : Princess Nourah bint Abdulrahman University

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen

Tar emot friska volontärer

Ja

Beskrivning

Inclusion Criteria:

  • Female undergraduate enrolled in the Graphic Design and Digital Media programme at Princess Nourah bint Abdulrahman University
  • Use of a computer for at least one month before the study
  • Able to read and understand English
  • Provided written informed consent

Exclusion Criteria:

  • Diagnosis of Sjögren syndrome
  • Diagnosis of keratoconjunctivitis sicca
  • Use of medications known to reduce tear production, for example antihistamines
  • Use of isotretinoin

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Yogic eye exercise programme
All participants received the same intervention: a 13-minute session of yogic relaxation and strengthening eye exercises, performed three days per week for four consecutive weeks (12 sessions).

A 13-minute sequence performed three days per week for four consecutive weeks (12 sessions in total).

Relaxation component: slow blinking; gazing at a fine detail of a distant target; acupressure massage of periocular points.

Strengthening component: eye-rolling movements; nose-tip gazing (focus on the extended thumb, move it slowly toward the nose tip, hold five seconds, move away; repeat twice, approximately 25 seconds per cycle).

Delivery: one supervised group training session before baseline, written and illustrated instructions, then independent home practice with same-day reporting of each completed session in a monitored group thread.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change from baseline in total symptom score at week 4
Tidsram: Baseline and week 4
Arithmetic mean of all nine self-reported symptom items - five ocular (eye dryness, red eye, foreign body sensation, blurred vision, excessive tearing) and four musculoskeletal (shoulder pain, back pain, loss of sensation in the fingers, loss of sensation in the hands) - each rated on a 4-point Likert scale (1 = never, 2 = rarely, 3 = sometimes, 4 = always). The total score ranges from 1 to 4; lower scores indicate fewer symptoms. Collected by self-completed electronic questionnaire.
Baseline and week 4

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change from baseline in ocular symptom domain score at week 4
Tidsram: Baseline and week 4
Mean of five self-reported ocular symptom items - eye dryness, red eye, foreign body sensation, blurred vision and excessive tearing - each rated on a 4-point Likert scale (1 = never to 4 = always). The domain score ranges from 1 to 4; lower scores indicate fewer symptoms.
Baseline and week 4
Change from baseline in muscular symptom domain score at week 4
Tidsram: Baseline and week 4
Mean of four self-reported musculoskeletal symptom items - shoulder pain, back pain, loss of sensation in the fingers and loss of sensation in the hands - each rated on a 4-point Likert scale (1 = never to 4 = always). The domain score ranges from 1 to 4; lower scores indicate fewer symptoms.
Baseline and week 4
Change from baseline in each individual symptom item at week 4
Tidsram: Baseline and week 4
Each of the nine symptom items analysed separately: eye dryness, red eye, foreign body sensation, blurred vision, excessive tearing, shoulder pain, back pain, loss of sensation in the fingers, loss of sensation in the hands. Each is rated on a 4-point Likert scale (1 = never to 4 = always); lower scores indicate fewer symptoms.
Baseline and week 4

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Baseline screen-use behaviour
Tidsram: Baseline
Descriptive characterisation of daily computer use (<2, 2-4, 4-6, >6 hours), daily screen viewing in darkness (same bands), and whether computer use was continuous or interrupted by breaks.
Baseline

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

15 mars 2021

Primärt slutförande (Faktisk)

16 april 2021

Avslutad studie (Faktisk)

16 april 2021

Studieregistreringsdatum

Först inskickad

7 september 2026

Först inskickad som uppfyllde QC-kriterierna

7 september 2026

Första postat (Faktisk)

11 september 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

16 september 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

13 september 2026

Senast verifierad

1 september 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • KingSaudU_20-0528E
  • 20-0528E (Annan identifierare: Princess Nourah bint Abdulrahman University Institutional Review Board (IRB registration with KACST: H-01-R-059))

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

JA

IPD-planbeskrivning

The de-identified participant-level dataset and the analysis code that support the findings are held by the corresponding author.

Tidsram för IPD-delning

Available on request from the date of publication, indefinitely.

Kriterier för IPD Sharing Access

Requests should be directed to the corresponding author and will be considered on reasonable scientific grounds.

IPD-delning som stöder informationstyp

  • STUDY_PROTOCOL
  • SAV
  • ANALYTIC_CODE
  • CSR

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera